179 results on '"Kuo, Hsiou‐Ting"'
Search Results
2. PSMA imaging as a non-invasive tool to monitor inducible gene expression in vivo
3. Development, preclinical evaluation and preliminary dosimetry profiling of SB03178, a first-of-its-kind benzo[h]quinoline-based fibroblast activation protein-α-targeted radiotheranostic for cancer imaging and therapy
4. Synthesis and Evaluation of Novel 68Ga-Labeled [D-Phe6,Leu13ψThz14]bombesin(6-14) Analogs for Cancer Imaging with Positron Emission Tomography
5. Synthesis and Evaluation of Novel 68 Ga-Labeled [D-Phe 6 ,Leu 13 ψThz 14 ]bombesin(6-14) Analogs for Cancer Imaging with Positron Emission Tomography.
6. Unnatural amino acid substitutions to improve in vivo stability and tumor uptake of 68Ga-labeled GRPR-targeted TacBOMB2 derivatives for cancer imaging with positron emission tomography
7. Stabilization of 68Ga-labeled [Thz14]Bombesin(7–14) analogue for imaging gastrin-releasing peptide receptor expression with positron emission tomography
8. Synthesis and Preclinical Evaluation of Three Novel 68Ga-labeled PSMA-FAP Heterodimeric Tracers for Imaging of Prostate Cancer
9. Synthesis and evaluation of a 68Ga-labeled PSMA-targeting tracer with a rigid linker to reduce kidney and salivary gland uptake
10. Effects of adding an albumin binder chain on [177Lu]Lu-DOTATATE
11. Unnatural amino acid substitutions to improve in vivo stability and tumor uptake of 68Ga-labeled GRPR-targeted TacBOMB2 derivatives for cancer imaging with positron emission tomography.
12. Synthesis and Evaluation of 99mTc-Labeled PSMA-Targeted Tracers Based on the Lys-Urea-Aad Pharmacophore for Detecting Prostate Cancer with Single Photon Emission Computed Tomography
13. Synthesis and Preclinical Evaluation of Novel 68Ga-Labeled (R)-Pyrrolidin-2-yl-boronic Acid-Based PET Tracers for Fibroblast Activation Protein-Targeted Cancer Imaging
14. P-148 - Development of a novel 68Ga-labeled benzo[h]quinoline-based FAP-targeted PET tracer: Synthesis, preclinical evaluation, and comparison with [68Ga]Ga-FAPI-04
15. P-127 - Stabilization of 68Ga-labeled [Thz14]Bombesin(7–14) analogue for imaging gastrin-releasing peptide receptor expression with positron emission tomography
16. P-122 - Synthesis and evaluation of a 68Ga-labeled PSMA-targeting tracer with a rigid linker to reduce kidney and salivary gland uptake
17. P-119 - Synthesis and Preclinical Evaluation of Three Novel 68Ga-labeled PSMA-FAP Heterodimeric Tracers for Imaging of Prostate Cancer
18. Supplementary Data from Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 Radioligands
19. Data from Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 Radioligands
20. Novel 68Ga-Labeled Pyridine-Based Fibroblast Activation Protein-Targeted Tracers with High Tumor-to-Background Contrast
21. Imidazolium‐methylene‐trifluoroborate: A novel radioprosthetic group validated with preclinical 18 F‐Positron Emission Tomography imaging of Prostate Specific Membrane Antigen in mice
22. 68Ga-Labeled [Thz14]Bombesin(7–14) Analogs: Promising GRPR-Targeting Agonist PET Tracers with Low Pancreas Uptake
23. Synthesis and Preclinical Evaluation of Three Novel 68Ga-Labeled Bispecific PSMA/FAP-Targeting Tracers for Prostate Cancer Imaging
24. Lys-urea-Aad, Lys-urea-Cmc and Lys-urea-Cms as potential pharmacophores for the design of PSMA-targeted radioligands to reduce off-target uptake in kidneys and salivary glands
25. Synthesis and Evaluation of 99m Tc-Labeled PSMA-Targeted Tracers Based on the Lys-Urea-Aad Pharmacophore for Detecting Prostate Cancer with Single Photon Emission Computed Tomography.
26. Reducing the Kidney Uptake of High Contrast CXCR4 PET Imaging Agents via Linker Modifications
27. Synthesis and Preclinical Evaluation of Novel 68 Ga-Labeled (R)-Pyrrolidin-2-yl-boronic Acid-Based PET Tracers for Fibroblast Activation Protein-Targeted Cancer Imaging.
28. Imidazolium‐methylene‐trifluoroborate: A novel radioprosthetic group validated with preclinical 18F‐Positron Emission Tomography imaging of Prostate Specific Membrane Antigen in mice.
29. What a difference an additional methylene makes: replacing Glu with Aad in the Lys-urea-Glu pharmacophore to reduce kidney and salivary gland uptake of PSMA-targeting radiopharmaceuticals
30. 177Lu-labeled Lys-urea-Aad-based PSMA-targeting radiotherapeutic agents with low uptake in mouse kidneys and salivary glands
31. Lanostane triterpenoids and sterols from Antrodia camphorata
32. Novel 68 Ga-Labeled Pyridine-Based Fibroblast Activation Protein-Targeted Tracers with High Tumor-to-Background Contrast.
33. 68 Ga-Labeled [Thz 14 ]Bombesin(7–14) Analogs: Promising GRPR-Targeting Agonist PET Tracers with Low Pancreas Uptake.
34. Synthesis and Preclinical Evaluation of Three Novel 68 Ga-Labeled Bispecific PSMA/FAP-Targeting Tracers for Prostate Cancer Imaging.
35. Effect of charged amino acid side chain length on lateral cross-strand interactions between carboxylate- and guanidinium-containing residues in a β-hairpin
36. Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 Radioligands
37. What a difference a methylene makes: replacing Glu with Asp or Aad in the Lys-urea-Glu pharmacophore of PSMA-targeting radioligands to reduce kidney and salivary gland uptake
38. Effect of side chain length on intrahelical interactions between carboxylate- and guanidinium-containing amino acids
39. A Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor–Positive Prostate Cancer
40. Helix formation and capping energetics of arginine analogs with varying side chain length
41. 177Lu-Labeled Albumin-Binder–Conjugated PSMA-Targeting Agents with Extremely High Tumor Uptake and Enhanced Tumor-to-Kidney Absorbed Dose Ratio
42. Evaluation of Met-Val-Lys as a Renal Brush Border Enzyme-Cleavable Linker to Reduce Kidney Uptake of 68Ga-Labeled DOTA-Conjugated Peptides and Peptidomimetics
43. Toward18F‐Labeled Theranostics: A Single Agent that Can Be Labeled with18F,64Cu, or177Lu
44. [nat/44Sc(pypa)]−: Thermodynamic Stability, Radiolabeling, and Biodistribution of a Prostate-Specific-Membrane-Antigen-Targeting Conjugate
45. Comparison of biological properties of [177Lu]Lu-ProBOMB1 and [177Lu]Lu-NeoBOMB1 for GRPR targeting
46. tBu4octapa-alkyl-NHS for metalloradiopeptide preparation
47. Synthesis and evaluation of an 18F-labeled boramino acid analog of aminosuberic acid for PET imaging of the antiporter system xC−
48. P-276 - What a difference an additional methylene makes: replacing Glu with Aad in the Lys-urea-Glu pharmacophore to reduce kidney and salivary gland uptake of PSMA-targeting radiopharmaceuticals
49. O-48 - 177Lu-labeled Lys-urea-Aad-based PSMA-targeting radiotherapeutic agents with low uptake in mouse kidneys and salivary glands
50. [68Ga]Ga/[177Lu]Lu-BL01, a Novel Theranostic Pair for Targeting C-X-C Chemokine Receptor 4
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.